NEW YORK – Luminex announced Monday that it has applied to the US Food and Drug Administration for 510(k) clearance of the Verigene II Respiratory Flex Assay (RSP Flex), a multiplexed test for simultaneous detection and identification of common viruses and bacteria from nasopharyngeal swabs obtained from a person suspected of having a respiratory tract infection.